Concepedia

Publication | Closed Access

Dosage of capecitabine and cyclophosphamide combination therapy in patients with metastatic breast cancer.

16

Citations

19

References

2007

Year

Shinji Ohno, Shoshu Mitsuyama, Kazuo Tamura, Reiki Nishimura, Maki Tanaka, Yuzo Hamada, Shoji Kuroki
PubMed

Abstract

The recommended all oral capecitabine/cyclophosphamide combination regimen is well tolerated and active in MBC, and is being evaluated in a phase II study in anthracycline-pretreated MBC.

References

YearCitations

Page 1